Recent Articles from GlobeNewswire
Conference highlights scientific progress and collaboration by bringing together leading FTD researchers and clinicians from around the world
By Association for Frontotemporal Degeneration · Via GlobeNewswire · October 5, 2026
New agreement expands collaboration through remembrance, education, community engagement and support for Gold Star Family initiatives nationwide.
By Wreaths Across America · Via GlobeNewswire · October 5, 2026
OCALA, Fla., Oct. 05, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today highlighted recent media coverage of the antiviral potential of Ampligen® (rintatolimod), the Company’s investigational dsRNA and highly selective TLR3 agonist immunomodulator.
By AIM ImmunoTech Inc. · Via GlobeNewswire · October 5, 2026
Preliminary Fiscal Q4 2026 Product Revenue of $3.8 Million
By NeuroOne Medical Technologies Corporation · Via GlobeNewswire · October 5, 2026
NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Tigo Energy, Inc. (“Tigo Energy” or the “Company”) (NASDAQ: TYGO) on behalf of investors that purchased or otherwise acquired Tigo Energy securities between February 24, 2026 and August 4, 2026 (the “Class Period”).
By Kaplan Fox & Kilsheimer, LLP · Via GlobeNewswire · October 5, 2026
NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hyliion Holdings Corp. (“Hyliion” or the “Company”) (NYSE: HYLN) on behalf of investors that purchased or otherwise acquired Hyliion securities between May 12, 2026 and June 23, 2026 (the “Class Period”).
By Kaplan Fox & Kilsheimer, LLP · Via GlobeNewswire · October 5, 2026
SAN FRANCISCO, Oct. 05, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (Nasdaq: IRTC) today announced that it completed the previously announced acquisition of Vital Connect, Inc. ("VitalConnect"), a leader in wearable biosensor technology and ambulatory cardiac monitoring.
By iRhythm · Via GlobeNewswire · October 5, 2026
NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against DICK’s Sporting Goods, Inc. (“Dick’s Sporting Goods” or the “Company”) (NYSE: DKS) on behalf of investors that purchased or otherwise acquired Dick’s Sporting Goods common stock between September 8, 2025 and August 24, 2026 (the “Class Period”).
By Kaplan Fox & Kilsheimer, LLP · Via GlobeNewswire · October 5, 2026
The Phase 1/2 ABILITY-1 Clinical Trial is evaluating MDNA11 in expansion cohorts comprised of patients with advanced and metastatic gastrointestinal, endometrial, and melanoma cancers
By Medicenna Therapeutics Corp. · Via GlobeNewswire · October 5, 2026
HOUSTON, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Westlake Royal Building Products™ (Westlake Royal), a Westlake company (NYSE: WLK), has consolidated two of its roofing brands — US Tile® Clay Roofing Products and Newpoint™ Concrete Roof Tile — under one national brand name: US Tile® Concrete and Clay Roofing. Consolidating clay and concrete roofing products under a single portfolio reflects Westlake Royal’s continued investment in the category and simplifies how customers specify, source and work with tile roofing solutions while requiring no changes to products, warranties, or customer support.
By Westlake Royal Building Products · Via GlobeNewswire · October 5, 2026
PHILADELPHIA, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Axalta Coating Systems (NYSE: AXTA), a leading global coatings company, will release its third quarter 2026 financial results at 6 a.m. ET on Thursday, October 29, 2026. The release and supporting materials will be posted to Axalta’s Investor Relations site.
By Axalta Coating Systems LLC · Via GlobeNewswire · October 5, 2026
LONDON and CAMBRIDGE, Mass., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Beacon Therapeutics, a leading clinical-stage biotechnology company with a mission to save and restore vision in people with rare and prevalent ocular diseases, today announces that Fierce Biotech has named it one of 2026’s Fierce 15 biotechnology companies, designating it as one of the most innovative and promising private biotechnology companies in the industry.
By Beacon Therapeutics (USA), Inc. · Via GlobeNewswire · October 5, 2026
The award-winning toy company has reimagined its best-selling Air Toobz, with Air Toobz Evo, a play system that brings more ways to build, experiment, and play; all at a lower price point
By Fat Brain Toys · Via GlobeNewswire · October 5, 2026
Agreement strengthens cooperation between two major trade gateways in the Americas through information sharing, technical collaboration, and joint efforts to support cargo connectivity
By DP World · Via GlobeNewswire · October 5, 2026
New session-based workflow brings structure to dealer-to-dealer trading alongside enhanced disclosure and price transparency
By Octaura · Via GlobeNewswire · October 5, 2026
LOS ANGELES, CA, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Avocado Green Mattress, the leader in certified organic mattresses and sustainable sleep, has announced its partnership with Sweet Dreams Furniture & Mattress, bringing Avocado’s certified organic mattresses and sleep products to customers throughout the Charlotte and Lake Norman area.
By Avocado Green Mattress · Via GlobeNewswire · October 5, 2026
ROSEVILLE, Minn., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Hawkins, Inc. (Nasdaq: HWKN) announced today that it expects to release its financial results for its second quarter fiscal 2027 ended September 27, 2026 after the market closes on October 26, 2026 at approximately 4:10 p.m. Eastern Time.
By Hawkins, Inc. · Via GlobeNewswire · October 5, 2026
License of up to 20 years and reciprocal share exchange would entitle RYET to a 10% royalty on qualifying technology receipts and 560,000 BGLC shares as Malaysia accelerates public healthcare digitalization
By Ruanyun Edai Technology Inc. · Via GlobeNewswire · October 5, 2026
Michael Lynch to succeed Paul Rosenthal as Chair; Bill Jackson and David Zalman named Co-Managing Partners; Dana Rosenfeld to continue as Senior Advisor
By Kelley Drye & Warren LLP · Via GlobeNewswire · October 5, 2026
Recognition notes Sophos’ key strengths including strong up-front protection across web, exploit, and ransomware vectors, validated across multiple independent testing programs, which reduces analyst workload and alert volume
By Sophos Inc. · Via GlobeNewswire · October 5, 2026
NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Taboola (Nasdaq: TBLA), a global leader in delivering performance at scale for advertisers, today announced a new report, The Data Advantage, highlighting significant shifts and challenges that today’s advertisers face when running campaigns.
By Taboola, Inc. · Via GlobeNewswire · October 5, 2026
ALBANY, N.Y., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), a leading global contract, development and manufacturing organization (CDMO), today announced a strategic investment to expand its sterile API manufacturing capabilities for both steroid and non-steroid products in Valladolid, Spain. This expansion is set to be completed in the fourth quarter of 2028.
By Curia Global, Inc. · Via GlobeNewswire · October 5, 2026
Participation will help inform leading practices for responsible AI implementation in healthcare through peer learning, real-world case studies and practical implementation guidance
By Autonomize AI · Via GlobeNewswire · October 5, 2026
PHILADELPHIA , Oct. 05, 2026 (GLOBE NEWSWIRE) --
By Grabar Law Office · Via GlobeNewswire · October 5, 2026
SAN DIEGO, Oct. 05, 2026 (GLOBE NEWSWIRE) -- LPL Financial LLC announced today that Praxis Financial Partners advisors Scott Christian, CFP®, Cecil Loyd, CIMA®, Jay Gentry, CIMA® and Matt Dion have joined LPL Financial's broker-dealer and Registered Investment Advisor (RIA) platform. The team reported serving approximately $1.1 billion in advisory, brokerage and retirement plan assets* and joins LPL from Wells Fargo Advisors Financial Network.
By LPL Financial Holdings, Inc. · Via GlobeNewswire · October 5, 2026
Second tranche completes the strategic relationship announced on June 16, 2026, adding exposure to anorthosite — an aluminum-rich rock characteristic of the lunar highlands — for sustainable alumina, refractory systems, lunar regolith simulants and research into 3D-printed lunar construction materials
By Greenland Mines Ltd · Via GlobeNewswire · October 5, 2026
LOS ANGELES, CA, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), a global leader in AL Amyloidosis, today announced that it will present at the 45th Annual J.P. Morgan Healthcare Conference being held January 11-14, 2027 in San Francisco, CA.
By Immix Biopharma, Inc. · Via GlobeNewswire · October 5, 2026
NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (NASDAQ: BBNX) on behalf of investors that purchased or otherwise acquired Beta Bionics common stock between July 30, 2025 and February 24, 2026 (the “Class Period”).
By Kaplan Fox & Kilsheimer, LLP · Via GlobeNewswire · October 5, 2026
Companies to Meet Formally with FDA’s Center for Veterinary Medicine on November 19th for Pre-Submission Conference; U.S. Manufacturing Strategy Underway to Support Potential 2027 Veterinary Product Launch
By Endovia Health Sciences · Via GlobeNewswire · October 5, 2026
Peppermint Mocha flavor and a new Candy Cane Variety Pack Launches Just in Time for the Season
By 5-hour ENERGY · Via GlobeNewswire · October 5, 2026
Ares Secondaries funds' total commitment to the platform now exceeds $500 million
By Sabey Data Centers · Via GlobeNewswire · October 5, 2026
Expands technology portfolio and addressable market, with $500 million or more in expected annual cost synergies and immediate non-GAAP EPS accretion
By Skyworks Solutions, Inc. · Via GlobeNewswire · October 5, 2026
TORONTO, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Mink Ventures Corporation (TSXV:MINK) (“Mink” or the "Company") today announced it completed the drill program at its Rankin Ni, Cu, Co Property, located approximately 35km west of Timmins Ontario (Figure 1). At this time all drill core has been logged and samples for assay have been sent to lab and put on a priority rush request.
By Mink Ventures Corporation · Via GlobeNewswire · October 5, 2026
Solution combines digital power control, GaN technology, and hardware-based security to accelerate development of high-efficiency rack power systems based on the 800V DC OCP standard
By Navitas Semiconductor Corporation · Via GlobeNewswire · October 5, 2026
LONDON and GAITHERSBURG, Md., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies and candidates, today announced the online publication of an abstract submitted to the American College of Rheumatology (ACR) Convergence 2026 meeting being held November 6-11, 2026 in Orlando, Florida. Updated data from the ongoing Phase 1 CARLYSLE trial in patients with severe refractory systemic lupus erythematosus (srSLE) will be presented in a poster on November 10.
By Autolus Therapeutics plc · Via GlobeNewswire · October 5, 2026
Index rises to 146 as sales increase +2.2% year over year and +0.7% month over month
By Fiserv, Inc. · Via GlobeNewswire · October 5, 2026
New DRS UK capability will support growing demand for counter-UAS, air defence and active protection system applications
By Leonardo DRS, Inc. · Via GlobeNewswire · October 5, 2026
Company to participate in 2026 Maxim Growth Summit (October 14) and Regional Biotechnology Conference (October 15)
By Aprea Therapeutics · Via GlobeNewswire · October 5, 2026
BOSTON, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced it awarded inducement grants on October 1, 2026 to two new employees as a material inducement to employment under Bicara’s 2026 Inducement Plan.
By Bicara Therapeutics Inc. · Via GlobeNewswire · October 5, 2026
FRISCO, TX, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Comstock Resources, Inc. (NYSE:CRK) plans to release its third quarter 2026 results on November 4, 2026 after the market closes and host its quarterly conference call at 10:00 a.m. CT on November 5, 2026 to discuss the third quarter results.
By Comstock Resources, Inc. · Via GlobeNewswire · October 5, 2026
PITTSBURGH, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Axe Compute Inc. (NASDAQ: AGPU) today announced that it completed its acquisition from Duos Technologies Group, Inc. (“Duos”) of 100% of the special purpose vehicle (the “SPV”) that owns the Axe Compute AI cluster in Columbus, Georgia (the “Georgia Cluster”) on September 30, 2026. At closing, Axe Compute paid off the SPV’s asset-backed loan facility of approximately $87.8 million, with no new equity issued. The remaining consideration consists of a $42.9 million deferred purchase price payable to Duos in monthly installments of $715,000, with any unpaid balance due in full by the earlier of twelve months after signing and the date Axe Compute enters into a financing secured by the Georgia Cluster. Axe Compute expects to pay the deferred purchase price directly from cash flows generated by the Georgia Cluster. Axe Compute expects to generate approximately $364.6 million in revenue over the life of the customer agreement, with a significant expected improvement to estimated contract gross margin. In addition, the Georgia AI Cluster customer agreement has been extended from three years to five years, running through 2031 with renewal options thereafter.
By Axe Compute Inc · Via GlobeNewswire · October 5, 2026
RESTON, Va., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Science Applications International Corp. (NASDAQ: SAIC), a leading mission integrator supporting defense, space, intelligence, and civilian agencies, today announced it has completed the acquisition of Information Security Corporation (ISC).
By SAIC, Inc. · Via GlobeNewswire · October 5, 2026
NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against GoDaddy Inc. (“GoDaddy” or the “Company”) (NYSE: GDDY) on behalf of investors that purchased or otherwise acquired GoDaddy common stock between September 3, 2025 and February 24, 2026 (the “Class Period”).
By Kaplan Fox & Kilsheimer, LLP · Via GlobeNewswire · October 5, 2026
Repayment of Oak Street Funding Term Loan Eliminates Approximately $1 Million of Annual Principal, Interest and Fee Payments
By Reliance Global Group, Inc. · Via GlobeNewswire · October 5, 2026
ATLANTA, Oct. 05, 2026 (GLOBE NEWSWIRE) -- ApolloMD is strengthening its partnership with the Emergency Medicine Foundation (EMF) through a new $15,000 research grant focused on emergency physician well-being and a $5,000 contribution to advance EMF’s work in emergency medicine research and education.
By ApolloMD Inc. · Via GlobeNewswire · October 5, 2026
DUBAI, United Arab Emirates, Oct. 05, 2026 (GLOBE NEWSWIRE) -- AIR Global PLC (“AIR” or the “Company”) (NASDAQ: AIIR), a global leader in advanced flavored inhalation technologies and pioneer of next-generation nicotine delivery systems, today announced that Crown Switch™, developed in partnership with Greentank Innovations Corp. (“Greentank”), a global leader of advanced vaporization hardware and technology, has been named Best Vape Device of the Year at the InterTabac World Alternative Awards. Crown Switch™, AIR’s first rechargeable pod vape system, debuted in Germany last year, and AIR plans to bring the product to market in the United States in the future. AIR’s Crown Switch™ is powered by Greentank’s Quantum Chip™ atomization technology.
By AIR Global · Via GlobeNewswire · October 5, 2026
Amended Kentucky Power agreement advances the second 500 MW phase into 2029 amid strong customer interest
By TeraWulf Inc. · Via GlobeNewswire · October 5, 2026
New Model Context Protocol (MCP) connector brings Wood Mackenzie's proprietary energy insights, data and analytical capabilities directly into Microsoft Copilot, enabling faster, more confident decisions
By Wood Mackenzie · Via GlobeNewswire · October 5, 2026
Presentations include real-world XPHOZAH® (tenapanor) data and new insights into hyperphosphatemia management and outcomes
By Ardelyx, Inc. · Via GlobeNewswire · October 5, 2026
AUSTIN, Texas, Oct. 05, 2026 (GLOBE NEWSWIRE) -- FTC Solar, Inc. (Nasdaq: FTCI), a leading provider of solar tracker systems, software, and engineering services, announced today that it has entered into an amended credit agreement with its lenders, relating primarily to the principal prepayment terms and the financial covenants that would have applied during the remainder of 2026.
By FTC Solar, Inc · Via GlobeNewswire · October 5, 2026
BRENTWOOD, Tenn., Oct. 05, 2026 (GLOBE NEWSWIRE) -- CoreCivic, Inc. (NYSE: CXW) ("CoreCivic") announced today that it will release its 2026 third quarter financial results after the market closes on Wednesday, November 4, 2026. A live broadcast of CoreCivic's conference call will begin at 10:00 a.m. central time (11:00 a.m. eastern time) on Thursday, November 5, 2026.
By CoreCivic, Inc. · Via GlobeNewswire · October 5, 2026
ORION CORPORATION PRESS RELEASE 05 OCTOBER 2026 at 8:00am ET
By Orion Oyj · Via GlobeNewswire · October 5, 2026
– Expands patient access to opioid-sparing pain control and advances 5x30 strategy –
By Pacira BioSciences · Via GlobeNewswire · October 5, 2026
New collaboration combines Zscaler Autonomous Application Shield with Lightwell from IBM and Red Hat to help organizations reduce exposure between vulnerability disclosure and patch deployment through inline protection and validated remediation
By Zscaler, Inc. · Via GlobeNewswire · October 5, 2026
MALVERN, Pa., Oct. 05, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio” or the “Company”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the U.S. Food and Drug Administration has granted 510(k) clearance for the Company's Liora Monofilament Scaffold (“Liora”) product.
By TELA Bio, Inc. · Via GlobeNewswire · October 5, 2026
NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Magnite (Nasdaq: MGNI), the largest independent sell-side advertising company, will announce its financial results for the third quarter ended September 30, 2026 after the market close on Wednesday, November 4, 2026. The Company will host a conference call at 1:30 PM (PT) / 4:30 PM (ET) the same day to discuss its financial results and outlook.
By Magnite, Inc. · Via GlobeNewswire · October 5, 2026
SAN DIEGO, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a technology company in defense, national security, and global markets, today announced multiple contract awards totaling over $100 million to develop prototype mission applications and cyber capabilities providing space intelligence data in support of joint operations across the space and cyberspace domains.
By Kratos Defense & Security Solutions, Inc. · Via GlobeNewswire · October 5, 2026
Multi-year expansion of the companies’ 2025 agreement to use Gate’s Molecular Gate drug discovery engine to design molecular gate medicines for Lilly targets
By Gate Bioscience · Via GlobeNewswire · October 5, 2026
Lease of the Liberty Magona business unit is now effective, opening a new phase for one of Italy’s historic producers of cold-rolled, galvanized and pre-painted steel
By Sizzle Acquisition Corp. II · Via GlobeNewswire · October 5, 2026
Veteran legal services executive to lead Angeion Group’s Corporate Bankruptcy Services and accelerate growth in corporate restructuring administration
By Angeion Group · Via GlobeNewswire · October 5, 2026
WASHINGTON, Oct. 05, 2026 (GLOBE NEWSWIRE) -- The Multidisciplinary Association for Psychedelic Studies (MAPS) announced a new strategic partnership with the International Alliance of Psychedelic Therapy Practitioners (Psychedelic Therapy Alliance), a professional association formed in 2023 for practitioners offering psychedelic-assisted therapy in legal settings.
By Multidisciplinary Association for Psychedelic Studies (MAPS) · Via GlobeNewswire · October 5, 2026
AssureChain, a dedicated subnet of MindChain, will run every insurance function on-chain, while MindChain provides settlement and anchoring to Ethereum
By MindWave Innovations Inc. · Via GlobeNewswire · October 5, 2026
By Osisko Gold Group Inc. · Via GlobeNewswire · October 5, 2026
ROCHESTER, NEW YORK, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Syntec Optics Holdings, Inc. (Nasdaq: OPTX) (“Syntec Optics” or the “Company”), a leading provider of deep-tech products to defense, space, and AI data centers, today announced recurring production orders for actuators in NASA's Artemis III rockets.
By Syntec Optics · Via GlobeNewswire · October 5, 2026
Trial follows promising MAR002 Phase 1 clinical trial results that demonstrated deep and durable IGF-1 suppression with PK properties that may enable dosing as infrequently as once every two weeks, compared to the daily subcutaneous injections required by the current standard of care
By Lisata Therapeutics, Inc. · Via GlobeNewswire · October 5, 2026
STMicroelectronics announces status of common share repurchase program
By STMicroelectronics International NV · Via GlobeNewswire · October 5, 2026
LONDON, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Coveron, an identity theft and scam protection service developed by Nord Security, is proud to announce that it has successfully completed SOC 2 Type II certification. Coveron concluded the audit with zero exceptions and recommendations, underlining the brand's commitment to protecting its customers' data.
By Coveron · Via GlobeNewswire · October 5, 2026
BOSTON, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Forward Therapeutics, Inc. (“Forward” or the “Company”), a clinical-stage biotechnology company developing oral small molecule therapies for inflammation-driven diseases, today announced positive Phase 1 clinical and preclinical data for FT2109, its novel, potential best-in-class oral selective TNFR1 signaling inhibitor. The data are included in two abstracts accepted for presentation at the American College of Rheumatology (ACR) Convergence 2026, taking place November 6–11 in Orlando, Florida.
By Forward Therapeutics · Via GlobeNewswire · October 5, 2026
Global ISO/IEC 42001 certification underscores Altus’ commitment to delivering trusted, transparent and secure AI solutions for the CRE industry
By Altus Group Limited · Via GlobeNewswire · October 5, 2026
-- Global, first-in-human study underway designed to evaluate safety, tolerability, and initial clinical efficacy of PM577a --
By Prime Medicine, Inc. · Via GlobeNewswire · October 5, 2026
EMERYVILLE, Calif., Oct. 05, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that the Company will host an Investor Day on Wednesday, October 21, 2026, in New York City. The live event will begin at 10:30am ET and include a Company presentation, KOL panel discussions and a live Q&A session.
By 4D Molecular Therapeutics, Inc. · Via GlobeNewswire · October 5, 2026
Continued purchases and organic accumulation drive approximately 11% growth in SOL holdings since the Company’s August 12 Earnings Update
By DeFi Development Corporation · Via GlobeNewswire · October 5, 2026
Mastercard to lead customer sales engagement under worldwide agreement, expanding Rezolve Ai’s distribution and subscription revenue opportunity
By Rezolve AI PLC · Via GlobeNewswire · October 5, 2026
Registration is now open for the April 13–15 event in Orlando, featuring expanded professional development, executive and frontline leadership programs, and an exclusive Process Safety Executive Roundtable.
By DEKRA North America, Inc. · Via GlobeNewswire · October 5, 2026
Appointment solidifies Cerevance’s leadership team as the company advances solengepras through Phase 3 development in Parkinson’s disease
By Cerevance, Inc. · Via GlobeNewswire · October 5, 2026
